🔎 Trials Near Me

Home › Blood Cancers › NCT06989489

Implementation of an Oral Chemotherapy Adherence Intervention

Recruiting

Design and Implementation of a Social Cognitive Theory-based Medication Adherence Intervention

Who can join

Ages 21 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Adult (age ≥21 years-old) patients
* Diagnosed with a solid or hematologic malignancy
* Monotherapy on oral anticancer agent on treatment for at least 6 months

Exclusion criteria:

* Patients on time-limited or intermittent therapy (non-continuous)
* Patients on comfort (end-of-life) care
* Patients enrolled on hospice

About the study

The goal of this study is to evaluate the effectiveness and usability of a newly developed oral anticancer agent adherence program implemented across 6 cancer clinics (two academic, two urban, and two rural). The study will include 160 adult participants with either solid tumors or hematologic malignancies who have been taking oral anticancer agents for at least six months.

This study will have two groups of participants, a pre- and post-implementation group. In the pre-implementation of the program group, investigators will administer a survey to the 80 participants and gather information about their medication prior to their enrollment of the program. Similarly, 80 participants who have been enrolled into this program for at least 6 months will serve as the post-implementation group. These patients will be administered the same survey. The results from both groups will be analyzed to see how effective the medication adherence program is.

What is being tested

Sponsor: UNC Lineberger Comprehensive Cancer Center · Participants: 160 · Started: May 28, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06989489

Locations in the U.S.

North CarolinaUNC Chapel Hill, Chapel Hill

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.